Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib Multiple Ascending Dose Study of the Safety, Tolerability, and CNS Availability of AZD0530 in Alzheimer's Disease

NCT01864655 is registered in ClinicalTrials.gov with Stephen M. Strittmatter as lead sponsor.

NCT NCT01864655
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01864655 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib Multiple Ascending Dose Study of the Safety, Tolerability, and CNS Availability of AZD0530 in Alzheimer's Disease
Lead sponsor
Stephen M. Strittmatter
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2013
Completion date
November 6, 2014
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease